Navigating an Optimal Treatment Course for Advanced Kidney Cancer von Teply, Benjamin

Volltext

Biomarkers for Treatment Response in Advanced Prostate Cancer von Asif, Samia, Teply, Benjamin A.

Volltext

Targeted Nanoparticle-Aptamer Bioconjugates for Cancer Chemotherapy in vivo von Farokhzad, Omid C., Cheng, Jianjun, Teply, Benjamin A., Sherifi, Ines, Jon, Sangyong, Kantoff, Philip W., Richie, Jerome P., Langer, Robert

Volltext

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers von Gu, Frank, Zhang, Liangfang, Teply, Benjamin A, Mann, Nina, Wang, Andrew, Radovic-Moreno, Aleksandar F, Langer, Robert, Farokhzad, Omid C

Volltext

Impact of Proton Pump Inhibitor Use on the Effectiveness of Immune Checkpoint Inhibitors in Advanced Cancer Patients von Peng, Kangning, Chen, Ken, Teply, Benjamin A., Yee, Gary C., Farazi, Paraskevi A., Lyden, Elizabeth R.

Volltext

Association of plasma NRP2 and VEGF-C levels with prostate cancer disease severity von Mullen, Sarah A, Das, Dipanwita, Ziamiavaghi, Negin, High, Robin, Datta, Kaustubh, Teply, Benjamin A

Volltext

Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study von Teply, Benjamin A, Wang, Hao, Luber, Brandon, Sullivan, Rana, Rifkind, Irina, Bruns, Ashley, Spitz, Avery, DeCarli, Morgan, Sinibaldi, Victoria, Pratz, Caroline F, Lu, Changxue, Silberstein, John L, Luo, Jun, Schweizer, Michael T, Drake, Charles G, Carducci, Michael A, Paller, Channing J, Antonarakis, Emmanuel S, Eisenberger, Mario A, Denmeade, Samuel R

Volltext

Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients von Muniyan, Sakthivel, Xi, Lei, Datta, Kaustubh, Das, Anindita, Teply, Benjamin A., Batra, Surinder K., Kukreja, Rakesh C.

Volltext

Current Management of Refractory Germ Cell Tumors von Abughanimeh, Omar, Teply, Benjamin A.

Volltext

Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery von Cheng, Jianjun, Teply, Benjamin A, Sherifi, Ines, Sung, Josephine, Luther, Gaurav, Gu, Frank X, Levy-Nissenbaum, Etgar, Radovic-Moreno, Aleksandar F, Langer, Robert, Farokhzad, Omid C

Volltext

A case of metastatic adenoid cystic (basal cell) carcinoma of the prostate: Systemic therapy for a rare disease von Trinh, Jonathan Q., Lele, Subodh M., Teply, Benjamin A.

Volltext

Development of bullous pemphigoid following radiation therapy combined with nivolumab for renal cell carcinoma: A case report of abscopal toxicities von Huynh, Linda My, Bonebrake, Benjamin T., DiMaio, Dominick J., Baine, Michael J., Teply, Benjamin A.

Volltext

Engineering of Targeted Nanoparticles for Cancer Therapy Using Internalizing Aptamers Isolated by Cell-Uptake Selection von Xiao, Zeyu, Levy-Nissenbaum, Etgar, Alexis, Frank, Lupták, Andrej, Teply, Benjamin A, Chan, Juliana M, Shi, Jinjun, Digga, Elise, Cheng, Judy, Langer, Robert, Farokhzad, Omid C

Volltext

A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus P... von Markowski, Mark C., Wang, Hao, Sullivan, Rana, Rifkind, Irina, Sinibaldi, Victoria, Schweizer, Michael T., Teply, Benjamin A., Ngomba, Nduku, Fu, Wei, Carducci, Michael A., Paller, Channing J., Marshall, Catherine H., Eisenberger, Mario A., Luo, Jun, Antonarakis, Emmanuel S., Denmeade, Samuel R.

Volltext

PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial von Stein, Mark N., Dumbrava, Ecaterina E., Teply, Benjamin A., Gergis, Usama S., Guiterrez, Martin E., Reshef, Ran, Subudhi, Sumit K., Jacquemont, Céline F., Senesac, Joseph H., Bayle, J. Henri, Scripture, Charity D., Chatwal, Monica S., Bilen, Mehmet A., Stadler, Walter M., Becerra, Carlos R.

Volltext

Extreme Response to High-dose Testosterone in BRCA2- and ATM-mutated Prostate Cancer von Teply, Benjamin A, Kachhap, Sushant, Eisenberger, Mario A, Denmeade, Samuel R

Volltext

Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling von Muniyan, Sakthivel, Rachagani, Satyanarayana, Parte, Seema, Halder, Sushanta, Seshacharyulu, Parthasarathy, Kshirsagar, Prakash, Siddiqui, Jawed A, Vengoji, Raghupathy, Rauth, Sanchita, Islam, Ridwan, Mallya, Kavita, Datta, Kaustubh, Xi, Lei, Das, Anindita, Teply, Benjamin A, Kukreja, Rakesh C, Batra, Surinder K

Volltext

Chemotherapy options in castration-resistant prostate cancer von Teply, Benjamin, Hauke, Ralph

Volltext

Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance) von Rosenberg, Jonathan E, Ballman, Karla A, Halabi, Susan, Atherton, Pamela J, Mortazavi, Amir, Sweeney, Christopher, Stadler, Walter M, Teply, Benjamin A, Picus, Joel, Tagawa, Scott T, Katragadda, Sreedhar, Vaena, Daniel, Misleh, Jamal, Hoimes, Christopher, Plimack, Elizabeth R, Flaig, Thomas W, Dreicer, Robert, Bajorin, Dean, Hahn, Olwen, Small, Eric J, Morris, Michael J

Volltext

Identification and management of toxicities from immune checkpoint-blocking drugs von Teply, Benjamin A, Lipson, Evan J

Volltext